Clinical Trial Update: Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase II study of six-hour low-dose gemcitabine plus cisplatin for advanced malignant pleural mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Advanced Malignant Pleural Mesothelioma | Phase 2 | Status: UNKNOWN